News

Pfizer Inc. plans to spend billions of dollars to join the race for a new type of cancer treatment. Similar to its competitors, Pfizer also plans to partner with a Chinese company. The company PFE ...
“MRNA probably is the most utilized vaccine in the history of humanity,” Pfizer CEO Dr. Albert Bourla said Friday, noting that there have been about 1.5 billion mRNA vaccine doses against ...
A colorectal cancer drug from Pfizer Inc. doubled survival time compared to the standard of care for a subset of patients, data that could change how physicians treat a particularly deadly form of ...
The three-treatment combination included a standard chemotherapy drug, an antibody drug called cetuximab and a pill from Pfizer called Braftovi, which targets a cancer mutation called BRAF V600E.
A precision oncology Pfizer drug now has clinical data showing it helped patients with colorectal cancer live longer, results that study investigators say could change the way physicians treat ...
But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an mRNA bird flu vaccine, claiming that “mRNA technology remains under-tested,” ...
(CNN) — Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services terminated a contract with drugmaker Moderna to develop an ...
A morning of powerful and inspiring speeches and wonderful cultural works. Anna Solomon is Wallpaper*’s Digital Staff Writer, working across all of Wallpaper.com’s core pillars, with special interests ...
Name a stock you sold recently. Pfizer Inc. PFE-N is a stock I’ve been selling aggressively in recent months after holding it in my client portfolios for about 20 years. I got frustrated with ...